| HFSA 2010 comprehensive heart failure practice guideline. J Lindenfeld, NM Albert, JP Boehmer, SP Collins, JA Ezekowitz, ... Journal of cardiac failure 16 (6), e1-194, 2010 | 2948* | 2010 |
| Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 2150 | 2021 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1498 | 2011 |
| Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure MR Costanzo, ME Guglin, MT Saltzberg, ML Jessup, BA Bart, JR Teerlink, ... Journal of the American College of Cardiology 49 (6), 675-683, 2007 | 1414 | 2007 |
| Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1074 | 2013 |
| Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... Circulation 131 (1), 54-61, 2015 | 828 | 2015 |
| The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ... Nature medicine 28 (3), 568-574, 2022 | 746 | 2022 |
| 2017 cardiovascular and stroke endpoint definitions for clinical trials KA Hicks, KW Mahaffey, R Mehran, SE Nissen, SD Wiviott, B Dunn, ... Journal of the American College of Cardiology 71 (9), 1021-1034, 2018 | 725 | 2018 |
| Warfarin and aspirin in patients with heart failure and sinus rhythm S Homma, JLP Thompson, PM Pullicino, B Levin, RS Freudenberger, ... New England Journal of Medicine 366 (20), 1859-1869, 2012 | 692 | 2012 |
| Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure BM Massie, CM O'Connor, M Metra, P Ponikowski, JR Teerlink, G Cotter, ... New England Journal of Medicine 363 (15), 1419-1428, 2010 | 619 | 2010 |
| Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... New England Journal of Medicine 384 (2), 105-116, 2021 | 614 | 2021 |
| Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure M Packer, W Colucci, L Fisher, BM Massie, JR Teerlink, J Young, ... JACC: Heart Failure 1 (2), 103-111, 2013 | 542 | 2013 |
| Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ... Journal of the American College of Cardiology 61 (2), 196-206, 2013 | 541 | 2013 |
| Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study JR Teerlink, M Metra, GM Felker, P Ponikowski, AA Voors, BD Weatherley, ... The Lancet 373 (9673), 1429-1439, 2009 | 530 | 2009 |
| Developing therapies for heart failure with preserved ejection fraction: current state and future directions J Butler, GC Fonarow, MR Zile, CS Lam, L Roessig, EB Schelbert, ... JACC: Heart Failure 2 (2), 97-112, 2014 | 478 | 2014 |
| Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial M Packer, SD Anker, J Butler, G Filippatos, JP Ferreira, SJ Pocock, ... Circulation 143 (4), 326-336, 2021 | 418 | 2021 |
| The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging … JGF Cleland, JR Teerlink, R Senior, EM Nifontov, JJV Mc Murray, ... The Lancet 378 (9792), 676-683, 2011 | 410 | 2011 |
| Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JJV McMurray, JR Teerlink, G Cotter, RC Bourge, JGF Cleland, ... Jama 298 (17), 2009-2019, 2007 | 410 | 2007 |
| Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee JC Fang, GA Ewald, LA Allen, J Butler, CAW Canary, M Colvin-Adams, ... Journal of cardiac failure 21 (6), 519-534, 2015 | 396 | 2015 |
| Diuretic response in acute heart failure: clinical characteristics and prognostic significance MAE Valente, AA Voors, K Damman, DJ Van Veldhuisen, BM Massie, ... European heart journal 35 (19), 1284-1293, 2014 | 390 | 2014 |
